BVS

Bioventus Inc. BVS

BVS
Bioventus Inc. TIVC
Tivic Health Systems, Inc. TLIS
Talis Biomedical Corporation BJDX
Bluejay Diagnostics, Inc. HSCS
HeartSciences Inc. NUWE
Nuwellis, Inc. BBLG
Bone Biologics Corporation NAOV
NanoVibronix, Inc. VVOS
Vivos Therapeutics, Inc. RPID
Rapid Micro Biosystems, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BVS TIVC TLIS BJDX HSCS NUWE BBLG NAOV VVOS RPID
6M -12.30 % -33.44 % -14.29 % 8.36 % -1.16 % -91.27 % -43.94 % -90.85 % 33.45 % 63.86 %
YTD -38.29 % -50.11 % -11.76 % -37.54 % -8.82 % -93.22 % -57.74 % -90.92 % -26.84 % 236.69 %
1Y -47.81 % -25.61 % -11.20 % -47.51 % -4.75 % -94.14 % -73.91 % -90.92 % 26.40 % 273.59 %
3Y 1.86 % -99.89 % -85.41 % -99.96 % -97.36 % -99.99 % -99.34 % -99.36 % -81.30 % 4.42 %
5Y -65.85 % -99.97 % -99.64 % -99.99 % -97.99 % -100.00 % -99.92 % -99.60 % -98.62 % -84.53 %
10Y -65.85 % -99.97 % -99.64 % -99.99 % -97.99 % -100.00 % -99.92 % -99.93 % -98.62 % -84.53 %
From the beginning -65.85 % -99.97 % -99.64 % -99.99 % -97.99 % -100.00 % -99.92 % -99.92 % -98.62 % -84.53 %

Dividend